A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Phase of Trial: Phase II
Latest Information Update: 30 Sep 2016
At a glance
- Drugs Difelikefalin (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Cara Therapeutics
- 30 Sep 2016 According to a Cara Therapeutics media release, the results from this trial presented at PAINWeek 2016.
- 15 Sep 2016 Results published in a Cara Therapeutics media release.
- 31 May 2016 According to a Cara Therapeutics media release, the results from this trial will be presented at the International Conference on Opioids.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History